A new study has revealed that intensive lifestyle intervention or a medication regimen can have a protective effect women with a history of gestational diabetes.

The Diabetes Prevention Program Outcomes Study (DPPOS) analyzed long-term metabolic health in 288 women who had a previous diagnosis of gestational diabetes and 1,226 mothers who did not have a history of gestational diabetes. Women with the condition were assigned to intensive lifestyle intervention, the diabetes medication metformin or a placebo. The intensive lifestyle intervention was aimed at reducing body weight by 7 percent and participating in moderate cardio exercise for 150 minutes every week.
During the DPPOS, the women continued to have their blood glucose levels measured twice a year for 6-years. Women with a history of gestational diabetes who were assigned to take metformin or undergo the intensive lifestyle intervention were less likely to develop type 2 diabetes than women who received the placebo. When assigned the placebo, women who had a history of gestational diabetes had a 48 percent higher risk of developing diabetes compared to women who were never diagnosed with the condition. Women who had been diagnosed with gestational diabetes and underwent intensive lifestyle intervention had a 35.2 percent reduction in their risk of developing type 2 diabetes, while the risk was reduced by 40.4 percent among women with a history of the condition who were assigned to take metformin.
Aroda said, "Medical and lifestyle interventions were remarkably effective at slowing the progression of type 2 diabetes in this at-risk population in both the short and long term."
The study is published in the Endocrine Society's 'Journal of Clinical Endocrinology & Metabolism'.
Source-Medindia